May 19, 2020
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Mar 04, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia
Feb 06, 2020
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Jan 27, 2020
Applied BioMath, LLC Announces Poster Presentation at the Tau2020 Global Conference
Dec 05, 2019
Samus Therapeutics Announces Presentation of PU-AD Phase 1 Data for Alzheimer's Disease at CTAD Congress
Nov 21, 2019
Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease
Nov 20, 2019
New Research Demonstrates Second Direct Link Between Inflammasome Activation and Alzheimer's Disease
Nov 07, 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Oct 22, 2019
Rainwater Charitable Foundation Announces Inaugural Winners As Part of World's Largest Prize Program for Brain Research
Sep 09, 2019
Axon Announces Positive Results From Phase II ADAMANT Trial for AADvac1 in Alzheimer's Disease
Aug 13, 2019
ProMIS Neurosciences Announces Second Quarter 2019 Results
Jul 23, 2019
Samus Therapeutics Launches PU-AD Clinical Program in Alzheimer's Disease
May 20, 2019
Asceneuron Appoints Experienced CNS Clinician Dr Eric Yuen to the Board of Directors
Apr 18, 2019
TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy
Mar 29, 2019
Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology
Mar 07, 2019
StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson's Disease is Published
Jan 17, 2019
Asceneuron Appoints Peter Van Vlasselaer as Chairman
Jan 02, 2019
APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene
Dec 12, 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Dec 06, 2018
Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer